Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study

Meeting Abstract: 925

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 63; no. 1 SUPP; p. 465A
Main Authors Houssel-Debry, Pauline, Coilly, Audrey, Fougerou-Leurent, Claire, Jezequel, Caroline, Duvoux, Christophe, Ledinghen, Victor De, Radenne, Sylvie, Kamar, Nassim, Leroy, Vincent, Di Martino, Vincent, d'Alteroche, Louis, Canva-Delcambre, Valerie, Conti, Filomena, Dumortier, Jérôme, Montialoux, Helene, Lebray, Pascal, Botta-Fridlund, Danielle, Anty, Rodolphe, Moreno, Christophe, Silvain, Christine, Besch, Camille, Perré, Philippe, Francoz, Claire, Abergel, Armand, Habersetzer, François, Debette-Gratien, Maryline, Rohel, Alexandra, Diallo, Alpha, Rossignol, Emilie, Danjou, Helene, Veislinger, Aurelie, Duclos-Vallée, Jean-Charles, Pageaux, Georges-Philippe
Format Journal Article
LanguageEnglish
Published Wiley-Blackwell 2017
Subjects
Life Sciences
Online AccessGet full text

Cover

More Information
Summary:Meeting Abstract: 925
ISSN:0270-9139
1527-3350